Literature DB >> 19710619

The course of myalgia and headache after electroconvulsive therapy.

Stephen H Dinwiddie1, Dezheng Huo, Ori Gottlieb.   

Abstract

BACKGROUND: Headache and myalgia seem to be common, though generally mild, complications of electroconvulsive therapy. Relatively little is known regarding the usual severity and time course of these complaints.
OBJECTIVE: This study examines the incidence, severity, and time course of myalgia and headache after electroconvulsive therapy.
METHODS: Patients rated severity of myalgia and headache immediately before treatment and again after recovery and at 2, 6, 12, and 24 hours posttreatment on a 10-point visual analog scale. Data were analyzed using random-effects linear models.
RESULTS: Severity of headache peaked 2 hours after treatment, returning to baseline by 24 hours and was relatively consistent within individuals between treatments. More severe posttreatment headache was reported by patients with a history of incapacitating headache and by those younger than 45 years. Headache was associated with increased duration of seizure. By contrast, myalgia was substantially more pronounced and lasted longer after the first treatment as compared with subsequent treatments. Severity of myalgia was not predicted by degree of fasciculations or motor activity, but was worse in patients younger than 45 years.
CONCLUSIONS: Posttreatment headache and myalgia are common but usually mild. Routine pretreatment using non-depolarizing agents is probably unnecessary in most cases but may have a role during the first treatment in a series. By contrast, preventive treatment may be warranted in those with history of severe headache and those who previously have had significant post-ECT headache.

Entities:  

Mesh:

Year:  2010        PMID: 19710619     DOI: 10.1097/YCT.0b013e3181b07c0a

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  7 in total

Review 1.  Neuromodulation for treatment-refractory major depressive disorder.

Authors:  Nir Lipsman; Tejas Sankar; Jonathan Downar; Sidney H Kennedy; Andres M Lozano; Peter Giacobbe
Journal:  CMAJ       Date:  2013-07-29       Impact factor: 8.262

2.  Patients' physical response to thiopental and alternative anesthetic agents in the setting of electroconvulsive therapy.

Authors:  Kayleigh Gordon; Donna M M Woloschuk; Ashley N Walus
Journal:  Can J Hosp Pharm       Date:  2014-11

3.  Increased Risk of Pain after Electroconvulsive Therapy among Depressed Patients: a Nationwide Study in Taiwan.

Authors:  Ching-En Lin; Chi-Hsiang Chun; Li-Fen Chen; Wu-Chien Chien
Journal:  Psychiatr Q       Date:  2020-03

4.  A randomized, double-blind, placebo-controlled trial on the role of preemptive analgesia with acetaminophen [paracetamol] in reducing headache following electroconvulsive therapy [ECT].

Authors:  Amila Isuru; Asiri Rodrigo; Chamara Wijesinghe; Dileepa Ediriweera; Shan Premadasa; Carmel Wijesekara; Lalith Kuruppuarachchi
Journal:  BMC Psychiatry       Date:  2017-07-28       Impact factor: 3.630

5.  The Incidence and Predictors of Headache and Myalgia in Patients After Electroconvulsive Therapy (ECT).

Authors:  Mohammad Haghighi; Abbas Sedighinejad; Bahram Naderi Nabi; Cyrus Emiralavi; Gelareh Biazar; Kaveh Mirmozaffari; Cyrus Zahedan; Mehdi Jafari
Journal:  Anesth Pain Med       Date:  2016-03-27

6.  Effects of low-dose ketamine on succinylcholine-induced postoperative myalgia in outpatient surgeries: a randomized, double-blind study.

Authors:  Karim Nasseri; Sanaz Arvien
Journal:  J Pain Res       Date:  2016-07-06       Impact factor: 3.133

7.  Effects of preemptive intravenous paracetamol and ibuprofen on headache and myalgia in patients after electroconvulsive therapy: A placebo-controlled, double-blind, randomized clinical trial.

Authors:  Erol Karaaslan; Sedat Akbas; Ahmet Selim Ozkan; Esra Porgali Zayman
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.